Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
19,290
-190 (-0.98%)
Jan 30, 2026, 3:30 PM KST
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 236.45 billion as of January 30, 2026. Its market cap has increased by 8.07% in one year.
Market Cap
236.45B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
11.16
Stock Price
19,290.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 236.45B, an increase of 712.00%. That is a compound annual growth rate of 7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 238.78B | -1.37% |
| Dec 30, 2025 | 242.09B | 9.24% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korea United Pharm | 280.57B |
| Boditech Med | 279.91B |
| JW Holdings | 262.23B |
| AptaBio Therapeutics | 252.28B |
| Daewon Pharmaceutical | 250.13B |
| Suheung | 236.84B |
| Chong Kun Dang Holdings | 235.41B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |